Pentostatin in steroid refractory acute graft versus host disease.

被引：0
作者：
Jacobsohn, D [1 ]
Margolis, J [1 ]
Anders, V [1 ]
Phelps, M [1 ]
Grever, M [1 ]
Vogelsang, G [1 ]
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Bone Marrow Transplant Program, Baltimore, MD 21218 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1628
引用
收藏
页码：420A / 420A
页数：1
相关论文
共 50 条
  • [1] Pentostatin in steroid-refractory acute graft-versus-host disease
    Bolaños-Meade, J
    Jacobsohn, DA
    Margolis, J
    Ogden, A
    Wientjes, MG
    Byrd, JC
    Lucas, DM
    Anders, V
    Phelps, M
    Grever, MR
    Vogelsang, GB
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2661 - 2668
  • [2] Treatment of steroid refractory acute intestinal graft versus host disease with pentostatin
    Klein, SA
    Dietrich, CF
    Wassmann, B
    Hermann, S
    Bug, G
    Hoelzer, D
    Martin, H
    BONE MARROW TRANSPLANTATION, 2002, 29 : S187 - S187
  • [3] LIMITED BENEFIT OF PENTOSTATIN SALVAGE THERAPY FOR STEROID REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE
    Alam, N.
    Viswabandya, A.
    How, J.
    Gupta, V
    Kim, D.
    Lipton, J.
    Messner, H.
    Kuruvilla, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S372 - S372
  • [4] Pentostatin in steroid-refractory chronic graft-versus-host disease
    Bolanos-Meade, J
    Jacobsohn, D
    Anders, V
    Higman, M
    Chen, A
    Phelps, M
    Vogelsang, GB
    BLOOD, 2005, 106 (11) : 513A - 514A
  • [5] Alemtuzumab in the treatment of steroid refractory acute Graft-versus-Host Disease.
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillermo
    Gonzalez-Llano, Oscar
    Cantu, Olga G.
    Gutierrez, Cesar H.
    Jaime-Perez, Jose Carlos
    Tarin-Arzaga, Luz
    Giralt, Sergio
    BLOOD, 2006, 108 (11) : 415B - 416B
  • [6] Salvage therapy with pentostatin for steroid-refractory graft-versus-host disease
    Leopardi, G
    Visani, G
    Giardini, C
    Sparaventi, G
    d'Adamo, F
    Nicolini, G
    Guiducci, B
    Barulli, S
    Malerba, L
    Lucesole, M
    Isidori, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S97 - S97
  • [7] Infliximab as treatment for steroid refractory acute and chronic graft-versus-host disease.
    Trenschel, R
    Ditschkowski, M
    Biersack, H
    Trampenau, C
    Steckel, NK
    Peceny, R
    Ottinger, H
    Elmaagacli, A
    Scheulen, ME
    Beelen, DW
    Schaefer, UW
    BLOOD, 2002, 100 (11) : 450B - 450B
  • [8] GLAT (Copaxone) for treatment of steroid-refractory acute graft versus host disease.
    Johnston, LJ
    Shizuru, JS
    Stockerl-Goldstein, KE
    Stuart, MJ
    Gasparetto, C
    Long, GD
    Rizzieri, DA
    Vredenburgh, JJ
    Blume, KG
    Negrin, RS
    Chao, NJ
    BLOOD, 2002, 100 (11) : 421A - 421A
  • [9] Steroid complications in patients with acute graft versus host disease.
    Betul, O
    Lee, H
    de Lima, M
    Couriel, D
    Giralt, S
    Saliba, R
    BLOOD, 2005, 106 (11) : 419B - 420B
  • [10] Infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease.
    Patriarca, F
    Sperotto, A
    Prosdocimo, S
    Skert, C
    Morreale, G
    Dini, G
    Bandini, G
    Milone, G
    Corradini, P
    Peccatori, J
    Fanin, R
    Bosi, A
    Bacigalupo, A
    BLOOD, 2003, 102 (11) : 451B - 451B
12345